Trial Profile
Randomized Clinical Trial to Study the Effect of Extended Release Niacin on Endothelial Function, Oxidative Stress and Endothelial Progenitor Cells in Patients With the Metabolic Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Niacin (Primary)
- Indications Metabolic syndrome
- Focus Pharmacodynamics
- Acronyms High-Ennd
- 05 May 2008 Actual patient number from clinicaltrials.gov record is 32.
- 08 Jan 2008 New trial record.